(Q40203636)

18 September 2017

A highly immunogenic fragment derived from Zaire Ebola virus glycoprotein elicits effective neutralizing antibody (English)

1 reference

18 September 2017

Orthoebolavirus zairense

0 references

Qiuyun Dai

3

0 references

author name string

Yu Wang

series ordinal

1

1 reference

PubMed ID

24930448

18 September 2017

Zhuguo Liu

series ordinal

2

1 reference

18 September 2017

12 June 2014

1 reference

18 September 2017

1 reference

18 September 2017

189

1 reference

18 September 2017

254-261

1 reference

Characteristics of Filoviridae: Marburg and Ebola viruses.

18 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

Expression of a hepatitis A virus antigen in Lactococcus lactis and Escherichia coli and evaluation of its immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

Reprogramming of murine and human somatic cells using a single polycistronic vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

Differential induction of cellular detachment by envelope glycoproteins of Marburg and Ebola (Zaire) viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

Influences of glycosylation on antigenicity, immunogenicity, and protective efficacy of ebola virus GP DNA vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

Descriptive analysis of Ebola virus proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

7 January 2021

Ebola haemorrhagic fever

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

Effective post-exposure treatment of Ebola infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

Requirements for cell rounding and surface protein down-regulation by Ebola virus glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

Drug targets in infections with Ebola and Marburg viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

Covalent modifications of the ebola virus glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

Ebolavirus glycoprotein structure and mechanism of entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

Complex of a Protective Antibody with Its Ebola Virus GP Peptide Epitope: Unusual Features of a Vλx Light Chain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

Ecologic and geographic distribution of filovirus disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

Importance of IgG2c isotype in the immune response to beta-amyloid in amyloid precursor protein/transgenic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

Enhanced protection against Ebola virus mediated by an improved adenovirus-based vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

Ebola virus glycoprotein toxicity is mediated by a dynamin-dependent protein-trafficking pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

Immune responses induced by DNA vaccines bearing Spike gene of PEDV combined with porcine IL-18.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

Identification of protective epitopes on ebola virus glycoprotein at the single amino acid level by using recombinant vesicular stomatitis viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

Faithful expression of multiple proteins via 2A-peptide self-processing: a versatile and reliable method for manipulating brain circuits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

Processing of the Ebola virus glycoprotein by the proprotein convertase furin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

Generation of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

Epitopes involved in antibody-mediated protection from Ebola virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

Antigenic characteristics of the complete and truncated capsid protein VP1 of enterovirus 71.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.06.001

10.1016/J.VIRUSRES.2014.06.001

7 January 2021

Identifiers

DOI

1 reference

18 September 2017

1 reference

PubMed ID

24930448